AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

BETAMETHASONE DIPROPIONATE + CLOTRIMAZOLE + GENTAMICIN SULFATE

16 registrations across 2 African markets— 15 active

Markets with BETAMETHASONE DIPROPIONATE + CLOTRIMAZOLE + GENTAMICIN SULFATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
KUMA CREAM (Each gram contains Betamethasone dipropionate/Clotrimazole/Gentamicin Sulfate 0.5%w/w/1%w/w/0.1%w/w)🇬🇭GhanaactiveDec 2030
KUMA CREAM (Each gram contains Betamethasone dipropionate/Clotrimazole/Gentamicin Sulfate 0.5%w/w/1%w/w/0.1%w/w)🇬🇭GhanaactiveDec 2030
CLONEM G - P CREAM🇬🇭GhanaactiveMar 2027
CLONEM G - P CREAM🇬🇭GhanaactiveMar 2027
TRISHIELD CREAM (Each 30gm tube contains Betamethasone dipropionate/Clotrimazole/Gentamicin Sulfate 0.05%w/w/1%w/w/0.1%w/w)🇬🇭GhanaactiveDec 2026
TRISHIELD CREAM (Each 30gm tube contains Betamethasone dipropionate/Clotrimazole/Gentamicin Sulfate 0.05%w/w/1%w/w/0.1%w/w)🇬🇭GhanaactiveDec 2026
TRENATO formerly Triple-T CREAM (Each 30g tube contains Betamethasone dipropionate/Clotrimazole/Gentamicin Sulfate 0.05%w/w/1.0%w/w/0.1%w/w)🇬🇭GhanaactiveNov 2026
MARODERM FORMERLY ZEROSPOT CREAM (Each tube contains Betamethasone dipropionate/Clotrimazole/Gentamicin Sulfate 0.1% w/w/ 1% w/w/ 0.1% w/w)🇬🇭GhanaactiveNov 2026
TRENATO formerly Triple-T CREAM (Each 30g tube contains Betamethasone dipropionate/Clotrimazole/Gentamicin Sulfate 0.05%w/w/1.0%w/w/0.1%w/w)🇬🇭GhanaactiveNov 2026
MARODERM FORMERLY ZEROSPOT CREAM (Each tube contains Betamethasone dipropionate/Clotrimazole/Gentamicin Sulfate 0.1% w/w/ 1% w/w/ 0.1% w/w)🇬🇭GhanaactiveNov 2026
ESKYZOLE CREAM🇬🇭GhanaexpiredSept 2026
ESKYZOLE CREAM🇬🇭GhanaactiveSept 2026
BETAMETHASONE DIPROPIONATE + CLOTRIMAZOLE + GENTAMICIN SULFATE
TOPICAL EXTERNAL CREAMS
🇺🇬UgandaREDDYS PHARMA LIMITEDactive
BETAMETHASONE DIPROPIONATE + CLOTRIMAZOLE + GENTAMICIN SULFATE
TOPICAL EXTERNAL CREAMS
🇺🇬UgandaREDDYS PHARMA LIMITEDactive
BETAMETHASONE DIPROPIONATE + CLOTRIMAZOLE + GENTAMICIN SULFATE
TOPICAL EXTERNAL CREAMS
🇺🇬UgandaREDDYS PHARMA LIMITEDactive
BETAMETHASONE DIPROPIONATE + CLOTRIMAZOLE + GENTAMICIN SULFATE
TOPICAL EXTERNAL CREAMS
🇺🇬UgandaREDDYS PHARMA LIMITEDactive

BETAMETHASONE DIPROPIONATE + CLOTRIMAZOLE + GENTAMICIN SULFATE in Africa — Regulatory Overview

BETAMETHASONE DIPROPIONATE + CLOTRIMAZOLE + GENTAMICIN SULFATE is registered across 2 African markets with 16 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Uganda. AfricaRegulatory refreshes this data daily from official government sources.

Of the 16 registrations, 15 (94%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.